Where does Genedia Biotech Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Genedia Biotech Co., Ltd. ranks #46,997 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Genedia Biotech Co., Ltd. hold?

Genedia Biotech Co., Ltd. holds 5 US utility patents granted between 2015 and 2019, spanning 4 technology areas.

What is Genedia Biotech Co., Ltd.'s Innovation Score?

Genedia Biotech Co., Ltd. has an Innovation Score of 18.7 out of 100 (5th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Genedia Biotech Co., Ltd.'s patent grant rate increasing or decreasing?

Genedia Biotech Co., Ltd.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Genedia Biotech Co., Ltd.'s patents?

Genedia Biotech Co., Ltd.'s patents average 9.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Genedia Biotech Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Genedia Biotech Co., Ltd.

Q: What technology areas does Genedia Biotech Co., Ltd. focus on?

Genedia Biotech Co., Ltd.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 4 patents. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Genedia ranks #46,997 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.

#46,997
of 49,997 US assignees by volume: 5th percentile
by Innovation Score (18.7/100): 9.0
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R46997 · Foreign Corporation #46,997 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #46,997/49,997
PHOTO-FINISH Gene Therapy Systems
CPC-NARROW C12Q · 4 areas
INNOV-LOW 18.7/100
CLAIMS-PAR 9.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gene Therapy Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Genedia Biotech · this assignee

19
3D Lighting… · lowest

7

What this shows Genedia's Innovation Score is 18.7/100 (5th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Genedia's grants concentrate

Genedia Biotech Co., Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 80% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2015. By volume, Genedia sits between GenFleet Therapeutics (Shanghai) Inc. and General Lighting Electronic Co., Ltd..

Genfleet Therapeu…

5
Gene Therapy Syst…

5
Genecraft

5
Genedesign

5
General Dynamics…

5
General Energy Re…

5
General Equipment…

5
General Lighting

5
Genedia Biotech ◀

5

What this shows Genedia holds 5 patents at rank #47,152, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Genedia

By rank, the assignees closest to #47,152 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Genedia's primary technology class.

Genedia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

19 5th percentile higher than 5% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Genedia Biotech Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	20.0%
2017	1	20.0%
2018	2	40.0%
2019	1	20.0%

Which technologies does Genedia Biotech Co., Ltd. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#46,997

of 49,997 tracked assignees

Innovation Score

18.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Genedia Biotech Co., Ltd.'s patent record in context - here's where to go next.

Genedia Biotech Co., Ltd.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 80% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #46,997 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Genedia Biotech Co., Ltd. against GenFleet Therapeutics (Shanghai) Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 18.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.